Frontiers in Oncology (Jun 2022)
Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms
Abstract
No abstracts available.Keywords